Inhibition of Colon Cancer Growth by Methylselenocysteine - induced Angiogenic Chemomodulation is influenced by Histological Characteristics of the Tumor

類似資料

• Architectural Heterogeneity in Tumors Caused by Differentiation Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound
  著者:: Rustum, Youcef M., 等
  出版事項: (2010)
• Hypoxia-Specific Drug Tirapazamine Does Not Abrogate Hypoxic Tumor Cells in Combination Therapy with Irinotecan and Methylselenocysteine in Well-Differentiated Human Head and Neck Squamous Cell Carcinoma A253 Xenografts
  著者:: Bhattacharya, Arup, 等
  出版事項: (2008)
• Bevacizumab Enhances the Therapeutic Efficacy of Irinotecan against Human Head and Neck Squamous Cell Carcinoma Xenografts
  著者:: Cao, Shousong, 等
  出版事項: (2011)
• Tumor Vascular Maturation and Improved Drug Delivery Induced by MethylSelenocysteine Leads to Therapeutic Synergy with Anticancer Drugs
  著者:: Bhattacharya, Arup, 等
  出版事項: (2008)
• Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α
  著者:: Chintala, Sreenivasulu, 等
  出版事項: (2010)